Eidos治疗(EIDX)

122.21 0.00 0.0%

今开:0.0昨收:122.21
最高:0.0 最低:0.0
涨停价:0.0跌停价:0.0
总市值:4.74931561E9

Eidos治疗的热门评论

Eidos治疗(EIDX)2021-01-08 05:06

$Eidos治疗(EIDX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-21-004141 Act: 34 Size: 27 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-12 20:36

$Eidos治疗(EIDX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-21-006788 Act: 34 Size: 293 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-12 20:45

$Eidos治疗(EIDX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-21-006803 Act: 34 Size: 293 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-14 05:18

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-001847 Size: 13 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-14 07:36

$Eidos治疗(EIDX)$ 内部交易: 2021-01-11,高级副总裁, Finance,Valle Franco ,卖出,1500普通股, $125.61查看全文

Eidos治疗(EIDX)2021-01-14 05:45

$Eidos治疗(EIDX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-21-008184 Act: 34 Size: 38 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-14 05:57

$Eidos治疗(EIDX)$ 425 Prospectuses and communications, business combinations Accession Number: 0001193125-21-008190 Act: 34 Size: 52 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-14 07:36

$Eidos治疗(EIDX)$ 内部交易: 2021-01-11,高级副总裁, Finance,Valle Franco ,期权,1500普通股, $7.24查看全文

Eidos治疗(EIDX)2021-01-14 07:36

$Eidos治疗(EIDX)$ 内部交易: 2021-01-12,高级副总裁, Finance,Valle Franco ,期权,1747普通股, $7.24查看全文

Eidos治疗(EIDX)2021-01-12 20:36

$Eidos治疗(EIDX)$ 8-K Current report, item 8.01 Accession Number: 0001193125-21-006784 Act: 34 Size: 529 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的最新评论

Eidos治疗(EIDX)2021-01-27 05:27

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017733 Size: 29 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-003286 Size: 7 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-017696 Act: 33 Size: 22 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017697 Act: 33 Size: 23 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017698 Act: 33 Size: 23 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-27 05:21

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017699 Act: 33 Size: 23 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-26 22:06

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017128 Act: 34 Size: 33 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-26 21:51

$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-21-017109 Act: 34 Size: 381 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-26 21:51

$Eidos治疗(EIDX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000105 Act: 34 Size: 2 KB 网页链接查看全文

Eidos治疗(EIDX)2021-01-21 05:27

$Eidos治疗(EIDX)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001193125-21-012447 Act: 34 Size: 208 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Eidos治疗的公告

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017733 Size: 29 KB 网页链接

$Eidos治疗(EIDX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-003286 Size: 7 KB 网页链接

$Eidos治疗(EIDX)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001193125-21-017696 Act: 33 Size: 22 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017697 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017698 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-21-017699 Act: 33 Size: 23 KB 网页链接

$Eidos治疗(EIDX)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-21-017128 Act: 34 Size: 33 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 1.01, 2.01, 2.03, 3.01, 3.03, 5.01, 5.02, 5.03, and 9.01 Accession Number: 0001193125-21-017109 Act: 34 Size: 381 KB 网页链接

$Eidos治疗(EIDX)$ 25-NSE Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities Accession Number: 0001354457-21-000105 Act: 34 Size: 2 KB 网页链接

$Eidos治疗(EIDX)$ 8-K Current report, items 5.07, 8.01, and 9.01 Accession Number: 0001193125-21-012447 Act: 34 Size: 208 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15